| 引用本文: | 陈刚,李剑波,高孟,高丽美,吴洁,姜云水,庄昉成.HMGB1对HPV16型重组腺病毒载体疫苗免疫效果的影响及机制研究[J].中国现代应用药学,2017,34(6):827-831. |
| CHEN Gang,LI Jianbo,GAO Meng,GAO Limei,WU Jie,JIANG Yunshui,ZHUANG Fangcheng.Effect and Mechanism of HMGB1 on Immune Efficacy of Recombinant Adenovirus Vector-based Human Papillomavirus-16 Vaccine[J].Chin J Mod Appl Pharm(中国现代应用药学),2017,34(6):827-831. |
|
| 摘要: |
| 目的 探讨高迁移率族蛋白B1（HMGB1）分子与人乳头瘤病毒（HPV）16型E6E7重组腺病毒载体疫苗免疫效果的关系及机制。方法 通过TC-1细胞移植诱导建立小鼠肿瘤模型，在接种HPV重组腺病毒载体疫苗的同时，给予注射HMGB1特异性拮抗剂HMGB1 A box，开展肿瘤抑制试验、小鼠免疫状态观察、肿瘤相关信号检测等研究。结果 A box蛋白与疫苗联用，可显著降低模型小鼠HMGB1血清水平，抑制肿瘤组织中NF-kB的mRNA高表达，提高疫苗的抗肿瘤活性。同时，它还可减少IL-4、促进IFN-γ产生，使体内免疫平衡由Th2向Th1偏移。和肿瘤模型对照组相比，在接种疫苗并注射A box蛋白后，由肿瘤引起的NF-κB、Bcl-2、c-IAP2、VEGF、MMP-9的表达提高、Bax表达降低均得到显著扭转。结论 HMGB1分子可以削弱HPV重组腺病毒载体疫苗的免疫效果，其机制可能是HMGB1在调节免疫平衡状态及控制肿瘤细胞的凋亡、浸润、转移等多层面均能参与并发挥重要作用。 |
| 关键词: HMGB1蛋白质 乳头状瘤病毒疫苗 接种 影响 机制 |
| DOI：10.13748/j.cnki.issn1007-7693.2017.06.009 |
| 分类号:R284.1；R917.101 |
| 基金项目:浙江省自然科学基金项目（LY14C080001） |
|
| Effect and Mechanism of HMGB1 on Immune Efficacy of Recombinant Adenovirus Vector-based Human Papillomavirus-16 Vaccine |
|
CHEN Gang, LI Jianbo, GAO Meng, GAO Limei, WU Jie, JIANG Yunshui, ZHUANG Fangcheng
|
|
Institute of Viral Diseases, Zhejiang Academy of Medical Sciences, Hangzhou 310053, China
|
| Abstract: |
| OBJECTIVE To study the influence of HMGB1 on the effect of recombinant adenovirus vector-based human papillomavirus-16 vaccine in mice model and explore the potential mechanism.METHODS HMGB1 antagonist, HMGB1 A box protein was injected into the model mice resulting from TC-1 cell transplantation. Anti-tumor test, immunological influence observation and tumor associated signaling molecules test were carried out with ecombinant adenovirus vector-based human papillomavirus-16 vaccination. RESULTS A box and vaccine combinating injection could decrease the serum HMGB1 level and inhibit NF-κB mRNA expression in model mice, accompanied with a lower tumor occurrence. It also regulated Th1/Th2 type cytokines balance by inducing IFN-γ and decreasing IL-4. And compared with model control group, HMGB1 inhibiting made the vaccine played a better performance in reducing NF-κB, Bcl-2, c-IAP2, VEGF, MMP-9 expression and increasing Bax expression in tumor model mice. CONCLUSION HMGB1 can block the immune response and anti-tumor effect of recombinant adenovirus vector-based human papillomavirus-16 vaccine in mouse model, and it probably resulted from HMGB1 playing an important role in cell apoptosis, tumor invasion and metastasis and immune balance regulation. |
| Key words: HMGB1 protein papillomavirus vaccines vaccination effect mechanism |
